UBS Group’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,769
| Closed | -$1.19K | – | 10060 |
|
2022
Q4 | $1.19K | Sell |
2,769
-677
| -20% | -$291 | ﹤0.01% | 8727 |
|
2022
Q3 | $2K | Sell |
3,446
-6,408
| -65% | -$3.72K | ﹤0.01% | 8769 |
|
2022
Q2 | $6K | Buy |
9,854
+9,853
| +985,300% | +$6K | ﹤0.01% | 7760 |
|
2022
Q1 | $0 | Sell |
1
-5,590
| -100% | – | ﹤0.01% | 10008 |
|
2021
Q4 | $6K | Buy |
5,591
+2,622
| +88% | +$2.81K | ﹤0.01% | 8213 |
|
2021
Q3 | $7K | Sell |
2,969
-6,526
| -69% | -$15.4K | ﹤0.01% | 7216 |
|
2021
Q2 | $28K | Sell |
9,495
-15,618
| -62% | -$46.1K | ﹤0.01% | 5933 |
|
2021
Q1 | $77K | Buy |
25,113
+22,835
| +1,002% | +$70K | ﹤0.01% | 5173 |
|
2020
Q4 | $11K | Sell |
2,278
-1,272
| -36% | -$6.14K | ﹤0.01% | 6421 |
|
2020
Q3 | $18K | Sell |
3,550
-35
| -1% | -$177 | ﹤0.01% | 5542 |
|
2020
Q2 | $20K | Buy |
3,585
+2,871
| +402% | +$16K | ﹤0.01% | 5729 |
|
2020
Q1 | $5K | Buy |
714
+110
| +18% | +$770 | ﹤0.01% | 6419 |
|
2019
Q4 | $7K | Buy |
604
+584
| +2,920% | +$6.77K | ﹤0.01% | 6402 |
|
2019
Q3 | $1K | Sell |
20
-11
| -35% | -$550 | ﹤0.01% | 6909 |
|
2019
Q2 | $12K | Sell |
31
-2,332
| -99% | -$903K | ﹤0.01% | 6094 |
|
2019
Q1 | $2.22M | Hold |
2,363
| – | – | ﹤0.01% | 2353 |
|
2018
Q4 | $2.48M | Buy |
+2,363
| New | +$2.48M | ﹤0.01% | 2273 |
|
2018
Q3 | – | Sell |
-7
| Closed | -$19K | – | 7255 |
|
2018
Q2 | $19K | Buy |
+7
| New | +$19K | ﹤0.01% | 5826 |
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 7144 |
|
2017
Q4 | – | Sell |
-2
| Closed | -$11K | – | 6763 |
|
2017
Q3 | $11K | Buy |
+2
| New | +$11K | ﹤0.01% | 5936 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 6586 |
|
2017
Q1 | – | Sell |
-3
| Closed | -$16K | – | 6911 |
|
2016
Q4 | $16K | Buy |
3
+2
| +200% | +$10.7K | ﹤0.01% | 5703 |
|
2016
Q3 | $4K | Buy |
+1
| New | +$4K | ﹤0.01% | 6287 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 6981 |
|